News | APMA
  • The Bylaws of the Council on Podiatric Medical Education mandate that publications produced by the council are to be reviewed by an Ad Hoc Advisory Committee six years following the adoption of revisions resulting from the previous Ad Hoc Advisory Committee review.

  • APMA submitted its formal comments to CMS on September 10 in response to CMS' proposed rule for the 2019 Medicare Physician Fee Schedule. We are incredibly proud of our members’ efforts to let CMS know its proposals related to separate E/M coding for DPMs are unacceptable.

  • This Weekend Is Your Last Chance to Tell CMS “No!” to Separate and Discriminatory Podiatric E/M Codes

    CMS is closing the opportunity to comment on its proposed changes for the 2019 Medicare Physician Fee Schedule this coming Monday, September 10. As a reminder, included among many proposed changes, CMS also included a proposal to require only podiatric physicians to use a separate set of E/M codes, which would pay significantly less. If you haven’t already utilized APMA’s eAdvocacy portal to express your opposition to this punitive proposal, we urge you to do so now.

  • In accordance with CPME procedures, interested individuals or institutions are invited to submit third-party comments with respect to compliance of the Midwestern University Arizona School of Podiatric Medicine in Glendale, AZ, with the standards and requirements of the council. The council will take into consideration all comments received by December 15 as part of the college’s on-site evaluation scheduled for January 22–25, 2019.

  • APMA submitted comments to CMS addressing CMS’s Request for Information (RFI) Regarding the Physician Self-Referral Law on August 24.

  • Instructions to Receive Your CECH Report from The National

    To receive your continuing education certificate of attendance and verification report, you must complete the overall meeting evaluation. Follow the below instructions to do so.

  • Novitas LCD Clarification Victory

    Since last November, APMA has been working with our Novitas Carrier Advisory Committee (CAC) representatives to clarify problematic language in Novitas’ Mycotic Nail Debridement Local Coverage Determination (LCD). As a result of the work of APMA and the CAC representatives, Novitas has changed the language, releasing a new LCD with an effective date of August 16, 2018. Under this new LCD, if the patient qualifies under “mycotic nail debridement” and debridement is performed without concomitant pharmacologic therapy, mycologic confirmation is expected.

  • As APMA has reported, CMS released its 2019 Medicare Physician Fee Schedule Proposed Rule [CMS-1693-P] that, if finalized, would require podiatrists to use different E/M codes from all other Medicare physicians. The codes would reimburse at a significantly lower rate.

  • CMS released the hardship exception application for MIPS-eligible clinicians for the 2018 performance period on August 8. There are three main categories of exception application types: PI Hardship Exception; Special Status Clinicians; and Extreme and Uncontrollable Circumstances.

  • Action Alert! Comment on E/M Code Discrimination

    On July 12, CMS released a proposed rule [CMS-1693-P] that, if finalized, would require podiatrists to use different E/M codes from all other Medicare physicians. The codes would reimburse at a significantly lower rate. APMA urges podiatrists, their patients, and other stakeholders to take action today to address this discriminatory and punitive proposed rule.

  • View News Archives

Read the lastest issue of APMA News from anywhere!